primary antisera against chat Search Results


90
GenScript corporation primary rabbit antisera against synthetic peptide ivsrlhrraqstat
Primary Rabbit Antisera Against Synthetic Peptide Ivsrlhrraqstat, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antisera+against+chat/primary+rabbit+antisera+against+synthetic+peptide+ivsrlhrraqstat/pmc03318458-90-14-32
Average 90 stars, based on 1 article reviews
primary rabbit antisera against synthetic peptide ivsrlhrraqstat - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
GenScript corporation primary rabbit antisera against synthetic peptide ivsrlhrr aqstat
Primary Rabbit Antisera Against Synthetic Peptide Ivsrlhrr Aqstat, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antisera+against+chat/primary+rabbit+antisera+against+synthetic+peptide+ivsrlhrr+aqstat/10__1128_slash_jb__06529___11-96-12-31
Average 90 stars, based on 1 article reviews
primary rabbit antisera against synthetic peptide ivsrlhrr aqstat - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Absolute Biotech goat primary antisera against muc5b (1:1000, everest biotech, upper heyford, uk)
<t>Muc5b</t> overexpression in the distal lung is associated with greater fibrogenesis following bleomycin. a , b In situ hybridization of human lung specimens from control and IPF subjects with MUC5B variant rs35705950. Arrowheads depict cells co-expressing SFTPC (red) and MUC5B (blue) in control bronchioles and IPF bronchiolar structures a and in control type 2 alveolar epithelia and IPF type 2 alveolar structures b . c Transgenic mice expressing Muc5b under control of the mouse Scgb1a1 and the human SFTPC promoters demonstrate Muc5b protein in conducting airways and in type 2 alveolar epithelia. d , e After repeated doses of bleomycin (2.5 U/kg, IT on day 0, 1.5 U/kg on days 14 and 28), SFTPC-Muc5b Tg demonstrated worse survival d and tissue injury e relative to wild type (+) littermates. Survival data in d were evaluated by χ 2 statistic using 17 Muc5b −/− , 16 Muc5b +/+ , 15 Scgb1a1- Muc5b Tg , 23 Scgb1a1-Muc5b +(wt) , 26 SFTPC- Muc5b Tg , and 25 SFTPC- Muc5b +(wt) , mice. f – i Scgb1a1- Muc5b Tg , Muc5b −/− , and control mice were treated IT with bleomycin as in d . To induce similar levels of fibrosis while limiting survivor bias, SFTPC-Muc5b Tg and controls received 2.0 U/kg bleomycin on day 0, followed by 1.0 U/kg on days 14 and 28. HP content increased in Scgb1a1-Muc5b Tg and SFTPC-Muc5b Tg but decreased in Muc5b −/− mice compared to wild type (+) controls for each strain. g – i Fibrillar collagen (magenta in g ) was assessed in peripheral lung tissues by confocal/multi-photon fluorescence microscopy with SHG. h , i Fibrillar collagen volumes following bleomycin were increased per mouse h and showed heterogeneous distributions i in Tg mice compared to controls. Data in i were analyzed by t- test ( n = 105 Scgb1a1-Muc5b Tg and 105 Scgb1a1-Muc5b +(wt) images, and n = 120 SFTPC-Muc5b Tg and 120 Scgb1a1-Muc5b +(wt) littermate images. Scale bars, 10 μm a , b , c , 250 μm e , and 100 μm g . In f and h , data are means ± sem, numbers in italics indicate n animals used per experiment, and p -values indicate differences determined by ANOVA with Holm-Sidak’s multiple comparisons test. In i , * indicates statistical significance ( p < 10 −5 )
Goat Primary Antisera Against Muc5b (1:1000, Everest Biotech, Upper Heyford, Uk), supplied by Absolute Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antisera+against+chat/goat+primary+antisera+against+muc5b++1+1000++everest+biotech++upper+heyford++uk+/pmc06299094-174-21-27
Average 90 stars, based on 1 article reviews
goat primary antisera against muc5b (1:1000, everest biotech, upper heyford, uk) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Serotech Inc rabbit primary antisera generated against avp ahp 372
<t>Muc5b</t> overexpression in the distal lung is associated with greater fibrogenesis following bleomycin. a , b In situ hybridization of human lung specimens from control and IPF subjects with MUC5B variant rs35705950. Arrowheads depict cells co-expressing SFTPC (red) and MUC5B (blue) in control bronchioles and IPF bronchiolar structures a and in control type 2 alveolar epithelia and IPF type 2 alveolar structures b . c Transgenic mice expressing Muc5b under control of the mouse Scgb1a1 and the human SFTPC promoters demonstrate Muc5b protein in conducting airways and in type 2 alveolar epithelia. d , e After repeated doses of bleomycin (2.5 U/kg, IT on day 0, 1.5 U/kg on days 14 and 28), SFTPC-Muc5b Tg demonstrated worse survival d and tissue injury e relative to wild type (+) littermates. Survival data in d were evaluated by χ 2 statistic using 17 Muc5b −/− , 16 Muc5b +/+ , 15 Scgb1a1- Muc5b Tg , 23 Scgb1a1-Muc5b +(wt) , 26 SFTPC- Muc5b Tg , and 25 SFTPC- Muc5b +(wt) , mice. f – i Scgb1a1- Muc5b Tg , Muc5b −/− , and control mice were treated IT with bleomycin as in d . To induce similar levels of fibrosis while limiting survivor bias, SFTPC-Muc5b Tg and controls received 2.0 U/kg bleomycin on day 0, followed by 1.0 U/kg on days 14 and 28. HP content increased in Scgb1a1-Muc5b Tg and SFTPC-Muc5b Tg but decreased in Muc5b −/− mice compared to wild type (+) controls for each strain. g – i Fibrillar collagen (magenta in g ) was assessed in peripheral lung tissues by confocal/multi-photon fluorescence microscopy with SHG. h , i Fibrillar collagen volumes following bleomycin were increased per mouse h and showed heterogeneous distributions i in Tg mice compared to controls. Data in i were analyzed by t- test ( n = 105 Scgb1a1-Muc5b Tg and 105 Scgb1a1-Muc5b +(wt) images, and n = 120 SFTPC-Muc5b Tg and 120 Scgb1a1-Muc5b +(wt) littermate images. Scale bars, 10 μm a , b , c , 250 μm e , and 100 μm g . In f and h , data are means ± sem, numbers in italics indicate n animals used per experiment, and p -values indicate differences determined by ANOVA with Holm-Sidak’s multiple comparisons test. In i , * indicates statistical significance ( p < 10 −5 )
Rabbit Primary Antisera Generated Against Avp Ahp 372, supplied by Serotech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antisera+against+chat/rabbit+primary+antisera+generated+against+avp+ahp+372/pm21156164-158-26-30
Average 90 stars, based on 1 article reviews
rabbit primary antisera generated against avp ahp 372 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
BioGenes GmbH primary antisera raised against vip
<t>Muc5b</t> overexpression in the distal lung is associated with greater fibrogenesis following bleomycin. a , b In situ hybridization of human lung specimens from control and IPF subjects with MUC5B variant rs35705950. Arrowheads depict cells co-expressing SFTPC (red) and MUC5B (blue) in control bronchioles and IPF bronchiolar structures a and in control type 2 alveolar epithelia and IPF type 2 alveolar structures b . c Transgenic mice expressing Muc5b under control of the mouse Scgb1a1 and the human SFTPC promoters demonstrate Muc5b protein in conducting airways and in type 2 alveolar epithelia. d , e After repeated doses of bleomycin (2.5 U/kg, IT on day 0, 1.5 U/kg on days 14 and 28), SFTPC-Muc5b Tg demonstrated worse survival d and tissue injury e relative to wild type (+) littermates. Survival data in d were evaluated by χ 2 statistic using 17 Muc5b −/− , 16 Muc5b +/+ , 15 Scgb1a1- Muc5b Tg , 23 Scgb1a1-Muc5b +(wt) , 26 SFTPC- Muc5b Tg , and 25 SFTPC- Muc5b +(wt) , mice. f – i Scgb1a1- Muc5b Tg , Muc5b −/− , and control mice were treated IT with bleomycin as in d . To induce similar levels of fibrosis while limiting survivor bias, SFTPC-Muc5b Tg and controls received 2.0 U/kg bleomycin on day 0, followed by 1.0 U/kg on days 14 and 28. HP content increased in Scgb1a1-Muc5b Tg and SFTPC-Muc5b Tg but decreased in Muc5b −/− mice compared to wild type (+) controls for each strain. g – i Fibrillar collagen (magenta in g ) was assessed in peripheral lung tissues by confocal/multi-photon fluorescence microscopy with SHG. h , i Fibrillar collagen volumes following bleomycin were increased per mouse h and showed heterogeneous distributions i in Tg mice compared to controls. Data in i were analyzed by t- test ( n = 105 Scgb1a1-Muc5b Tg and 105 Scgb1a1-Muc5b +(wt) images, and n = 120 SFTPC-Muc5b Tg and 120 Scgb1a1-Muc5b +(wt) littermate images. Scale bars, 10 μm a , b , c , 250 μm e , and 100 μm g . In f and h , data are means ± sem, numbers in italics indicate n animals used per experiment, and p -values indicate differences determined by ANOVA with Holm-Sidak’s multiple comparisons test. In i , * indicates statistical significance ( p < 10 −5 )
Primary Antisera Raised Against Vip, supplied by BioGenes GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antisera+against+chat/primary+antisera+raised+against+vip/pm23329259-62-46-52
Average 90 stars, based on 1 article reviews
primary antisera raised against vip - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Corning Life Sciences primary polyclonal rabbit antisera against eer-2/neu 800-874-8667
<t>Muc5b</t> overexpression in the distal lung is associated with greater fibrogenesis following bleomycin. a , b In situ hybridization of human lung specimens from control and IPF subjects with MUC5B variant rs35705950. Arrowheads depict cells co-expressing SFTPC (red) and MUC5B (blue) in control bronchioles and IPF bronchiolar structures a and in control type 2 alveolar epithelia and IPF type 2 alveolar structures b . c Transgenic mice expressing Muc5b under control of the mouse Scgb1a1 and the human SFTPC promoters demonstrate Muc5b protein in conducting airways and in type 2 alveolar epithelia. d , e After repeated doses of bleomycin (2.5 U/kg, IT on day 0, 1.5 U/kg on days 14 and 28), SFTPC-Muc5b Tg demonstrated worse survival d and tissue injury e relative to wild type (+) littermates. Survival data in d were evaluated by χ 2 statistic using 17 Muc5b −/− , 16 Muc5b +/+ , 15 Scgb1a1- Muc5b Tg , 23 Scgb1a1-Muc5b +(wt) , 26 SFTPC- Muc5b Tg , and 25 SFTPC- Muc5b +(wt) , mice. f – i Scgb1a1- Muc5b Tg , Muc5b −/− , and control mice were treated IT with bleomycin as in d . To induce similar levels of fibrosis while limiting survivor bias, SFTPC-Muc5b Tg and controls received 2.0 U/kg bleomycin on day 0, followed by 1.0 U/kg on days 14 and 28. HP content increased in Scgb1a1-Muc5b Tg and SFTPC-Muc5b Tg but decreased in Muc5b −/− mice compared to wild type (+) controls for each strain. g – i Fibrillar collagen (magenta in g ) was assessed in peripheral lung tissues by confocal/multi-photon fluorescence microscopy with SHG. h , i Fibrillar collagen volumes following bleomycin were increased per mouse h and showed heterogeneous distributions i in Tg mice compared to controls. Data in i were analyzed by t- test ( n = 105 Scgb1a1-Muc5b Tg and 105 Scgb1a1-Muc5b +(wt) images, and n = 120 SFTPC-Muc5b Tg and 120 Scgb1a1-Muc5b +(wt) littermate images. Scale bars, 10 μm a , b , c , 250 μm e , and 100 μm g . In f and h , data are means ± sem, numbers in italics indicate n animals used per experiment, and p -values indicate differences determined by ANOVA with Holm-Sidak’s multiple comparisons test. In i , * indicates statistical significance ( p < 10 −5 )
Primary Polyclonal Rabbit Antisera Against Eer 2/Neu 800 874 8667, supplied by Corning Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antisera+against+chat/primary+polyclonal+rabbit+antisera+against+eer+2+neu+800+874+8667/pm21528205-38-2-9
Average 90 stars, based on 1 article reviews
primary polyclonal rabbit antisera against eer-2/neu 800-874-8667 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Muc5b overexpression in the distal lung is associated with greater fibrogenesis following bleomycin. a , b In situ hybridization of human lung specimens from control and IPF subjects with MUC5B variant rs35705950. Arrowheads depict cells co-expressing SFTPC (red) and MUC5B (blue) in control bronchioles and IPF bronchiolar structures a and in control type 2 alveolar epithelia and IPF type 2 alveolar structures b . c Transgenic mice expressing Muc5b under control of the mouse Scgb1a1 and the human SFTPC promoters demonstrate Muc5b protein in conducting airways and in type 2 alveolar epithelia. d , e After repeated doses of bleomycin (2.5 U/kg, IT on day 0, 1.5 U/kg on days 14 and 28), SFTPC-Muc5b Tg demonstrated worse survival d and tissue injury e relative to wild type (+) littermates. Survival data in d were evaluated by χ 2 statistic using 17 Muc5b −/− , 16 Muc5b +/+ , 15 Scgb1a1- Muc5b Tg , 23 Scgb1a1-Muc5b +(wt) , 26 SFTPC- Muc5b Tg , and 25 SFTPC- Muc5b +(wt) , mice. f – i Scgb1a1- Muc5b Tg , Muc5b −/− , and control mice were treated IT with bleomycin as in d . To induce similar levels of fibrosis while limiting survivor bias, SFTPC-Muc5b Tg and controls received 2.0 U/kg bleomycin on day 0, followed by 1.0 U/kg on days 14 and 28. HP content increased in Scgb1a1-Muc5b Tg and SFTPC-Muc5b Tg but decreased in Muc5b −/− mice compared to wild type (+) controls for each strain. g – i Fibrillar collagen (magenta in g ) was assessed in peripheral lung tissues by confocal/multi-photon fluorescence microscopy with SHG. h , i Fibrillar collagen volumes following bleomycin were increased per mouse h and showed heterogeneous distributions i in Tg mice compared to controls. Data in i were analyzed by t- test ( n = 105 Scgb1a1-Muc5b Tg and 105 Scgb1a1-Muc5b +(wt) images, and n = 120 SFTPC-Muc5b Tg and 120 Scgb1a1-Muc5b +(wt) littermate images. Scale bars, 10 μm a , b , c , 250 μm e , and 100 μm g . In f and h , data are means ± sem, numbers in italics indicate n animals used per experiment, and p -values indicate differences determined by ANOVA with Holm-Sidak’s multiple comparisons test. In i , * indicates statistical significance ( p < 10 −5 )

Journal: Nature Communications

Article Title: Muc5b overexpression causes mucociliary dysfunction and enhances lung fibrosis in mice

doi: 10.1038/s41467-018-07768-9

Figure Lengend Snippet: Muc5b overexpression in the distal lung is associated with greater fibrogenesis following bleomycin. a , b In situ hybridization of human lung specimens from control and IPF subjects with MUC5B variant rs35705950. Arrowheads depict cells co-expressing SFTPC (red) and MUC5B (blue) in control bronchioles and IPF bronchiolar structures a and in control type 2 alveolar epithelia and IPF type 2 alveolar structures b . c Transgenic mice expressing Muc5b under control of the mouse Scgb1a1 and the human SFTPC promoters demonstrate Muc5b protein in conducting airways and in type 2 alveolar epithelia. d , e After repeated doses of bleomycin (2.5 U/kg, IT on day 0, 1.5 U/kg on days 14 and 28), SFTPC-Muc5b Tg demonstrated worse survival d and tissue injury e relative to wild type (+) littermates. Survival data in d were evaluated by χ 2 statistic using 17 Muc5b −/− , 16 Muc5b +/+ , 15 Scgb1a1- Muc5b Tg , 23 Scgb1a1-Muc5b +(wt) , 26 SFTPC- Muc5b Tg , and 25 SFTPC- Muc5b +(wt) , mice. f – i Scgb1a1- Muc5b Tg , Muc5b −/− , and control mice were treated IT with bleomycin as in d . To induce similar levels of fibrosis while limiting survivor bias, SFTPC-Muc5b Tg and controls received 2.0 U/kg bleomycin on day 0, followed by 1.0 U/kg on days 14 and 28. HP content increased in Scgb1a1-Muc5b Tg and SFTPC-Muc5b Tg but decreased in Muc5b −/− mice compared to wild type (+) controls for each strain. g – i Fibrillar collagen (magenta in g ) was assessed in peripheral lung tissues by confocal/multi-photon fluorescence microscopy with SHG. h , i Fibrillar collagen volumes following bleomycin were increased per mouse h and showed heterogeneous distributions i in Tg mice compared to controls. Data in i were analyzed by t- test ( n = 105 Scgb1a1-Muc5b Tg and 105 Scgb1a1-Muc5b +(wt) images, and n = 120 SFTPC-Muc5b Tg and 120 Scgb1a1-Muc5b +(wt) littermate images. Scale bars, 10 μm a , b , c , 250 μm e , and 100 μm g . In f and h , data are means ± sem, numbers in italics indicate n animals used per experiment, and p -values indicate differences determined by ANOVA with Holm-Sidak’s multiple comparisons test. In i , * indicates statistical significance ( p < 10 −5 )

Article Snippet: For immunohistochemistry, tissues were heated in citrate buffer for antigen retrieval (20 min boiling), and tissues were then incubated overnight in goat primary antisera against Muc5b (1:1000, Everest Biotech, Upper Heyford, UK) or with rabbit primary anti-mouse Muc5b antisera (1:20,000) .

Techniques: Over Expression, In Situ Hybridization, Variant Assay, Expressing, Transgenic Assay, Fluorescence, Microscopy

Muc5b overexpression in SFTPC-Muc5bTg mice is associated with impaired mucociliary transport. a Representative μOCT images of excised SFTPC-Muc5bTg mice trachea in comparison to trachea of wild type (+) littermate controls. b – e Quantitative metrics from image analysis reveal increased mucus layer depth b without significant alteration of periciliary layer (PCL) depth c in Tg mice compared to + controls. Functional analysis demonstrated reduced ciliary beat frequency d and diminished mucociliary transport rates e in Muc5b-overexpressing mice. Data in b – e are means ± sem and were analyzed by Mann–Whitney test

Journal: Nature Communications

Article Title: Muc5b overexpression causes mucociliary dysfunction and enhances lung fibrosis in mice

doi: 10.1038/s41467-018-07768-9

Figure Lengend Snippet: Muc5b overexpression in SFTPC-Muc5bTg mice is associated with impaired mucociliary transport. a Representative μOCT images of excised SFTPC-Muc5bTg mice trachea in comparison to trachea of wild type (+) littermate controls. b – e Quantitative metrics from image analysis reveal increased mucus layer depth b without significant alteration of periciliary layer (PCL) depth c in Tg mice compared to + controls. Functional analysis demonstrated reduced ciliary beat frequency d and diminished mucociliary transport rates e in Muc5b-overexpressing mice. Data in b – e are means ± sem and were analyzed by Mann–Whitney test

Article Snippet: For immunohistochemistry, tissues were heated in citrate buffer for antigen retrieval (20 min boiling), and tissues were then incubated overnight in goat primary antisera against Muc5b (1:1000, Everest Biotech, Upper Heyford, UK) or with rabbit primary anti-mouse Muc5b antisera (1:20,000) .

Techniques: Over Expression, Functional Assay, MANN-WHITNEY

P-2119 effectively cleaves mucus in vitro and in vivo, enhancing the acute clearance of inflammatory cells. a , b P-2119 hydrolyzed DTNB disulfide bonds more quickly than n-acetylcysteine (NAC) a , and at pH 6 P-2119 cleaved more bonds than NAC b . c In human saliva, P-2119 reduced MUC5B in salivary mucus at lower concentrations than NAC. d – g In concentrated normal human bronchial epithelial cell culture mucus (5% solids), P-2119 reduced MUC5B at a potency similar to that seen in saliva in c . Reduction of MUC5B by P-2119 dose dependently lowered mucus viscosity as demonstrated by enhanced mean square displacement (MSD) of fluorescent microspheres e , and as shown by improved macrorheological complex viscosity f that was strongly correlated with reduced molecular mass g . Data in e represent 900 technical and three biological replicates; data in f represent three technical and two biological replicates. Cyan symbols, vehicle; magenta symbols, P-2119. h – j In vivo effects of aerosolized P-2119 (68–135 mM for 60 min). h Wild-type mice challenged with LPS (20 μg, IT) 48 h prior to P-2119 aerosol. P-2119 decreased Muc5b mass detected by immunoblot of lung lavage fluid over a 120 min period. i SFTPC-Muc5b Tg mice were challenged with bleomycin (2.5 U/kg, IT) 7 d prior to P-2119 treatment (Tx). P-2119 caused Muc5b reduction detected by immunoblot 120 min post initiation of P-2119 aerosol. j The effect of P-2119-induced mucolysis on MCC was assessed by quantifying the acute elimination of leukocytes in lung lavage fluid obtained from bleomycin treated SFTPC-Muc5b Tg mice ( n = 9 vehicle and 12 P-2119 treated) and wild type (+) controls ( n = 12 vehicle and 13 P-2119 treated). Total cells were significantly lower in P-2119 treated mice compared to vehicle treated animals, reflecting decreases in all leukocyte subtypes in bleomycin-injured lungs. Data in a , e – g , and j are means ± sem. Data in a were analyzed between P-2119 and NAC treated groups using t -tests. Data in e – g were analyzed statistically on biological replicates: ANOVA of results between 0 mM vehicle and 0.1–10 mM P-2119 treatment groups e , f and linear regression of complex viscosity vs mass g

Journal: Nature Communications

Article Title: Muc5b overexpression causes mucociliary dysfunction and enhances lung fibrosis in mice

doi: 10.1038/s41467-018-07768-9

Figure Lengend Snippet: P-2119 effectively cleaves mucus in vitro and in vivo, enhancing the acute clearance of inflammatory cells. a , b P-2119 hydrolyzed DTNB disulfide bonds more quickly than n-acetylcysteine (NAC) a , and at pH 6 P-2119 cleaved more bonds than NAC b . c In human saliva, P-2119 reduced MUC5B in salivary mucus at lower concentrations than NAC. d – g In concentrated normal human bronchial epithelial cell culture mucus (5% solids), P-2119 reduced MUC5B at a potency similar to that seen in saliva in c . Reduction of MUC5B by P-2119 dose dependently lowered mucus viscosity as demonstrated by enhanced mean square displacement (MSD) of fluorescent microspheres e , and as shown by improved macrorheological complex viscosity f that was strongly correlated with reduced molecular mass g . Data in e represent 900 technical and three biological replicates; data in f represent three technical and two biological replicates. Cyan symbols, vehicle; magenta symbols, P-2119. h – j In vivo effects of aerosolized P-2119 (68–135 mM for 60 min). h Wild-type mice challenged with LPS (20 μg, IT) 48 h prior to P-2119 aerosol. P-2119 decreased Muc5b mass detected by immunoblot of lung lavage fluid over a 120 min period. i SFTPC-Muc5b Tg mice were challenged with bleomycin (2.5 U/kg, IT) 7 d prior to P-2119 treatment (Tx). P-2119 caused Muc5b reduction detected by immunoblot 120 min post initiation of P-2119 aerosol. j The effect of P-2119-induced mucolysis on MCC was assessed by quantifying the acute elimination of leukocytes in lung lavage fluid obtained from bleomycin treated SFTPC-Muc5b Tg mice ( n = 9 vehicle and 12 P-2119 treated) and wild type (+) controls ( n = 12 vehicle and 13 P-2119 treated). Total cells were significantly lower in P-2119 treated mice compared to vehicle treated animals, reflecting decreases in all leukocyte subtypes in bleomycin-injured lungs. Data in a , e – g , and j are means ± sem. Data in a were analyzed between P-2119 and NAC treated groups using t -tests. Data in e – g were analyzed statistically on biological replicates: ANOVA of results between 0 mM vehicle and 0.1–10 mM P-2119 treatment groups e , f and linear regression of complex viscosity vs mass g

Article Snippet: For immunohistochemistry, tissues were heated in citrate buffer for antigen retrieval (20 min boiling), and tissues were then incubated overnight in goat primary antisera against Muc5b (1:1000, Everest Biotech, Upper Heyford, UK) or with rabbit primary anti-mouse Muc5b antisera (1:20,000) .

Techniques: In Vitro, In Vivo, Cell Culture, Western Blot

P-2119 treatment results in reduced collagen deposition in the setting of excess Muc5b. a SFTPC-Muc5bTg mice were subjected to bleomycin challenge with a 2 wk P-2119 intervention protocol, with daily P-2119 treatments (Tx) or saline vehicle (Veh) exposures starting 7 or 56 d post bleomycin challenge and ending 24 h prior to tissue harvest. b – h Injury and fibrosis induced in bleomycin-treated mice exposed to saline vehicle were decreased in P-2119 treated animals. Compared to vehicle treated animals, P-2119 treated mice had significantly fewer leukocytes in lung lavage b , less hydroxyproline in lung homogenates at 10 wks c , and decreased peripheral lung fibrillar collagen d – h . In b – d , data are means ± sem, numbers in italics indicate n animals used per experiment, and p -values indicate differences determined by t -test with Welch’s correction for unequal variances. In e and f , * indicates statistical significance by t -test ( p < 0.00001). Histograms in e are from 15 Veh mice (225 images) and from 12 Tx mice (165 images); histograms in f are from 9 Veh mice (180 images) and from 6 Tx mice (120 images). Images in g and h show greater amounts of fibrillar collagen (red) in Veh vs. Tx groups. Scale bars, 100 μm g , h

Journal: Nature Communications

Article Title: Muc5b overexpression causes mucociliary dysfunction and enhances lung fibrosis in mice

doi: 10.1038/s41467-018-07768-9

Figure Lengend Snippet: P-2119 treatment results in reduced collagen deposition in the setting of excess Muc5b. a SFTPC-Muc5bTg mice were subjected to bleomycin challenge with a 2 wk P-2119 intervention protocol, with daily P-2119 treatments (Tx) or saline vehicle (Veh) exposures starting 7 or 56 d post bleomycin challenge and ending 24 h prior to tissue harvest. b – h Injury and fibrosis induced in bleomycin-treated mice exposed to saline vehicle were decreased in P-2119 treated animals. Compared to vehicle treated animals, P-2119 treated mice had significantly fewer leukocytes in lung lavage b , less hydroxyproline in lung homogenates at 10 wks c , and decreased peripheral lung fibrillar collagen d – h . In b – d , data are means ± sem, numbers in italics indicate n animals used per experiment, and p -values indicate differences determined by t -test with Welch’s correction for unequal variances. In e and f , * indicates statistical significance by t -test ( p < 0.00001). Histograms in e are from 15 Veh mice (225 images) and from 12 Tx mice (165 images); histograms in f are from 9 Veh mice (180 images) and from 6 Tx mice (120 images). Images in g and h show greater amounts of fibrillar collagen (red) in Veh vs. Tx groups. Scale bars, 100 μm g , h

Article Snippet: For immunohistochemistry, tissues were heated in citrate buffer for antigen retrieval (20 min boiling), and tissues were then incubated overnight in goat primary antisera against Muc5b (1:1000, Everest Biotech, Upper Heyford, UK) or with rabbit primary anti-mouse Muc5b antisera (1:20,000) .

Techniques: